Page 214 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

190 Constantina Yiannakis, Lorna Ward and Matthew David Morgan

[16] Bennett, R. W., Staker, L. V. Wegener's granulomatosis presenting as vertigo. West J.
Med. 1987; 146:359-361.

[17] Stone, J. H., Francis, H. W. Immune-mediated inner ear disease. Curr. Opin.
Rheumatol. 2000; 12:32-40.

[18] George, T. M., Cash, J. M., Farver, C., et al. Mediastinal mass and hilar adenopathy:
rare thoracic manifestations of Wegener's granulomatosis. Arthritis Rheum. 1997; 40:
1992-1997.

[19] Eschun, G. M., Mink, S., Sharma, S. Pulmonary interstitial fibrosis as a presenting
manifestation in perinuclear antineutrophilic cytoplasmic antibody microscopic
polyangiitis. Chest 2003; 123:297-301.

[20] Booth, A. D., Pusey, C. D. and Jayne, D. R. Renal vasculitis--an update in 2004.
Nephrol. Dial. Transplant. 2004; 19:1964-1868.

[21] Bajema, I. M., Hagen, E. C., van der Woude, F. J., et al. Wegener's granulomatosis: a
meta-analysis of 349 literary case reports. J. Lab. Clin. Med. 1997; 129:17-22.

[22] Jayne, D. The diagnosis of vasculitis. Best Pract. Res. Clin. Rheumatol. 2009; 23:445-
453.

[23] Berden, A. E., Ferrario, F., Hagen, E. C., et al. Histopathologic classification of ANCA-
associated glomerulonephritis. J. Am. Soc. Nephrol. 2010; 21:1628-1636.

[24] Berden, A. E., Jones, R. B., Erasmus, D. D., et al. Tubular lesions predict renal outcome
in antineutrophil cytoplasmic antibody-associated glomerulonephritis after rituximab
therapy. J. Am. Soc. Nephrol. 2012; 23:313-321.

[25] Calabrese, L. H., Molloy, E. S., Singhal, A. B. Primary central nervous system
vasculitis: progress and questions. Ann. Neurol. 2007; 62:430-432.

[26] Holle, J. U., Gross, W. L. Neurological involvement in Wegener's granulomatosis.
Curr. Opin. Rheumatol. 2011; 23:7-11.

[27] Keogh, K. A., Ytterberg, S. R., Fervenza, F. C., et al. Rituximab for Refractory
Wegener's Granulomatosis: Report of A Prospective, Open-Label Pilot Trial. Am. J.
Respir. Crit. Care Med. 2006; 173:180-187.

[28] Jennette, J. C., Falk, R. J. Small-vessel vasculitis. N. Engl. J. Med. 1997; 337:1512-
1523.

[29] Morelli, S., Gurgo Di Castelmenardo, A. M., et al. Cardiac involvement in patients with
Wegener's granulomatosis. Rheumatol. Int. 2000; 19:209-212.

[30] Knockaert, D. C. Cardiac involvement in systemic inflammatory diseases. Eur. Heart J.
2007; 28:1797-1804.

[31] Bligny, D., Mahr, A., Toumelin, P., et al. Predicting mortality in systemic Wegener's
granulomatosis: a survival analysis based on 93 patients. Arthritis Rheum. 2004; 51:83-
91.

[32] Aasarod, K., Iversen, B. M., Hammerstrom, J., et al. Wegener's granulomatosis: clinical
course in 108 patients with renal involvement. Nephrol. Dial. Transplant. 2000; 15:
611-618.

[33] Koldingsnes, W., Nossent, H. Predictors of organ damage and survival in Wegener's
granulomatosis. Rheumatology 2002; 41:572-581.

[34] Morgan, M., Savage, C. Vasculitis in the gastrointestinal tract. Best Pract. Res. Clin.
Gastroenterol. 2005; 19:215-233.

Complimentary Contributor Copy